Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|November 13, 2008
Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cellsSvetlana Marukian, Christopher T Jones, Linda Andrus, et al.
Biomedicines|December 23, 2020
Modulation of Early Host Innate Immune Response by an Avipox Vaccine Virus' Lateral Body ProteinEfstathios S Giotis, Stephen M Laidlaw, Susanna R Bidgood, et al.
Blood|October 19, 2007
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemiaEdgar D Charles, Rashidah M Green, Svetlana Marukian, et al.
Nature Communications|June 24, 2016
MAIT cells are activated during human viral infectionsBonnie van Wilgenburg, Iris Scherwitzl, Edward C Hutchinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 11, 2003
Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patientsJianhua Ni, Edgardo Hembrador, Adrian M Di Bisceglie, et al.
European Journal of Medicinal Chemistry|June 3, 2026
Cephalosporins are potent SARS-CoV-2 main protease inhibitorsDorian-Gabriel Muntean, Wojtek Treyde, Dóra Laczi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2004
Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virusRichard J Anderson, Carolyn M Hannan, Sarah C Gilbert, et al.
Blood|April 30, 2005
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis CDavid Butera, Svetlana Marukian, Amy E Iwamaye, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 28, 2013
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)Michael J Fuller, Benoit Callendret, Baogong Zhu, et al.
Pageof 6